Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasculopathy, Inflammation and Systemic Sclerosis (VISS)
NCT02562079Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Mar 2012
- Primary completion
- Dec 2016
- Countries
- 1
01
Overview
Trial (3 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Assessment of OX40L expression in endothelial cells and skin biopsies at Day 1. Started Mar 2012; status: completed.
Beyond the preview
Go deeper on NCT02562079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02562079.